FLOW-AF: A Study to Evaluate the Ablacon Electrographic FLOW EGF Technology

  • STATUS
    Recruiting
  • participants needed
    100
  • sponsor
    Ablacon, Inc.
Updated on 27 September 2021
arrhythmia
cardiac mapping

Summary

This study is to evaluate the Ablacon Electrographic Flow (EGF) algorithm technology (Ablamap Software).

Description

The objective of this study is to evaluate the reliability of the Ablacon Electrographic Flow (EGF) algorithm technology (Ablamap Software) to identify atrial fibrillation sources and guide ablation therapy in patients with persistent atrial fibrillation.

Details
Condition Atrial Fibrillation, Persistent, Atrial Fibrillation, Persistent, Atrial Fibrillation, Persistent
Treatment Ablamap Software
Clinical Study IdentifierNCT04473963
SponsorAblacon, Inc.
Last Modified on27 September 2021

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note